Ian Whitcombe - Concepedia

Author

Ian Whitcombe

Also Known As

I. W. A. WHITCOMBE, I. W. A. Whitcombe, I. Whitcombe, Ian W. A. Whitcombe, Ian W.A Whitcombe, Ian W.A. Whitcombe, Ian Whitcombe, Ian Whitcombe, Whitcombe, I.W.A.

Publications

645

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (United Kingdom)Roche (United Kingdom)University of Liverpool Imperial College London

About

Ian Whitcombe is an author at UCB Pharma (United Kingdom) specializing in medicine, drug discovery, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	354
2	Biochemistry	6	6	212
3	Natural Sciences	5	5	150
4	Biomolecular Engineering	2	2	34
5	Engineering	1	1	17

Ian Whitcombe

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors John Porter, Andrew Payne, Ben de Candole, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacological AgentPhenyl PyrazolesHeterocycle Chemistry	2008	117
Metabolomic Strategy for the Classification and Quality Control of Phytomedicine: A Case Study of Chamomile Flower (<i>Matricaria recutita</i>L.) Yulan Wang, Huiru Tang, Jeremy K. Nicholson, Planta Medica	2004	104
Automated Protein–Ligand Interaction Screening by Mass Spectrometry Hannah J. Maple, Rachel A. Garlish, Laura Rigau-Roca, Journal of Medicinal Chemistry Drug TargetHit IdentificationProtein AnalysisBiological Mass SpectrometryWide Dynamic Range	2011	71
Prediction of anti-plasmodial activity of Artemisia annua extracts: application of NMR spectroscopy and chemometrics Nigel J. Bailey, Yulan Wang, Julia Sampson, Journal of Pharmaceutical and Biomedical Analysis PhytoalexinAnti-plasmodial ActivityNmr SpectroscopyBiochemistryBioassay-guided Isolation	2004	62
CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir<i>in vitro</i> Victoria A. Eagling, Hugh Wiltshire, Ian Whitcombe, Xenobiotica	2002	61
Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation Robyn Fowler, Driton Vllasaliu, Francisco Fernández‐Trillo, Small	2013	61
4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase Rikki Alexander, Ahrani Balasundaram, Mark Batchelor, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ChemistryMedicineMechanism Of ActionPharmacotherapyChemical Biology	2008	42
Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation John Porter, Andrew Payne, Ian Whitcombe, Bioorganic & Medicinal Chemistry Letters Chemical BiologyBioactive ConformationBiochemistryMedicineNatural Sciences	2009	30
The synthesis and rotational isomerism of 1-amino-2-imidazol-4-ylethylphosphonic acid [phosphonohistidine, His(P)] and 1-amino-2-imidazol-2-ylethylphosphonic acid [phosphonoisohistidine, Isohis(P)] John H. Merrett, W. C. SPURDEN, W. A. Thomas, Journal of the Chemical Society Perkin Transactions 1 Conformational DifferencesRotational IsomerismBioorganic ChemistryEngineeringBiochemistry	1988	17
The design of inhibitors of protein kinase C; the solution conformation of staurosporine Peter D. Davis, Christopher H. Hill, W. A. Thomas, Journal of the Chemical Society Chemical Communications Protein AssemblyMolecular BiologyOrganic ChemistryChemical BiologySpectra-structure Correlation	1991	17

Page 1